Brief: vTv Therapeutics Reports Collaboration and License Agreement with affiliates of G42 Healthcare

vTv Therapeutics

01/06/2022 12:48

June 1 (Reuters) - vTv Therapeutics Inc  VTVT.O :
    * VTV THERAPEUTICS ANNOUNCES INVESTMENT BY AND ENTRY INTO
COLLABORATION AND LICENSE AGREEMENT WITH AFFILIATES OF G42
HEALTHCARE
    * VTV THERAPEUTICS INC - ENTRY INTO AGREEMENTS THAT INCLUDE
A $25
MILLION INVESTMENT BY G42 INVESTMENTS AI HOLDING RSC LTD
    * VTV THERAPEUTICS INC - G42 INVESTMENTS ACQUIRED 10,386,274
SHARES OF CLASS A COMMON STOCK OF VTV AT AN ISSUE PRICE OF
$2.407 PER SHARE
    * VTV-AGREEMENTS SET FORTH TERMS UNDER WHICH VTV,AFFILIATE
OF G42
PLAN TO COLLABORATE ON CLINICAL TRIALS FOR PHARMACEUTICAL
PRODUCTS THAT CONTAIN TTP399
    * VTV -DEALS GIVE POTENTIAL ISSUANCE OF $30 MILLION IN
ADDITIONAL
CLASS A COMMON STOCK TO G42 IF FDA APPROVES MARKETING,SALE OF
PRODUCT CONTAINING TTP399

Source text for Eikon:  ID:nGNX5L94BF 
Further company coverage:  VTVT.O 

 ((Reuters.Briefs@thomsonreuters.com;))